- The company is working to be a major provider of premier CBD products
- ETST’S three subsidiaries focus on developing its role as a global leader in the CBD space
- ETST is forward-thinking – centering on the science, research and studies of its high-grade hemp CBD oil
Based in Doral, Florida, Earth Science Tech, Inc. (OTC: ETST) is a biotechnology company with three wholly owned subsidiaries. Through these, it operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. CBD offered by the company is in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products.
CBD is a naturally occurring constituent of industrial hemp oil. ETST is advancing its efforts to be a major provider of premier CBD products. Business Insider recently noted (http://ibn.fm/z2Jqd) that “CBD is estimated to make up a roughly $1 billion industry, but the recent federal approval could make it even more lucrative by jump-starting demand for CBD-based products.”
ETST’s wholly owned subsidiaries are Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and KannaBidioiD, Inc. These subsidiaries center on developing ETST’s role as an international leader in the CBD space. They also focus on expanding the company’s work in the pharmaceutical and medical device sectors.
Earth Science Pharmaceutical’s mission is to develop low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Cannabis Therapeutics’ emphasis is on developing new, pioneering, cannabinoid-based pharmaceutical and nutraceutical products. KannaBidioiD (KBD) focuses on products for the recreational cannabis space.
Furthermore, ETST has its Canadian subsidiary, Canna Inno Laboratories, Inc. (Montreal, Québec), which it acquired last year. The company established this subsidiary to give it a position in the province and to provide it with access to government grants.
ETST’s three-year strategic plan, created in 2017, includes expansion into Canada. The company recently attended the largest Cannabis Expo in Canada, the Lift and Co. Expo.
In a news release, Dr. Michel Aubé, ETST’S chief executive officer and chief scientific officer, said, “I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and visionary lenders who are active in financing cannabis industry growth. We will pursue some of these new relationships in the coming months.”
ETST is now developing three new CBD formulas that are under a provisory patent. One CBD formula product is a neuron protector and the other is a breast protector. The third CBD formula is a new kind of superfood with distinctive organoleptic properties.
ETST is moving forward concentrating on the science, research and study of its high-grade hemp CBD oil as a nutraceutical and dietary supplement. In addition, the company has completed the set-up of its scientific advisory council with a team of recognized scientists. Furthermore, it is making its entry into the medical devices market via collaborative partnerships. ETST’s management team, with decades of experience in the nutraceutical, dietary supplement and life sciences sectors, is steering the company in an exciting direction.
For more information, visit the company’s website at www.EarthScienceTech.com
